Comparative effectiveness of Molixan and Glutoxim in the model of toxic liver lesions with anti-tuberculosis drugs

Due to the high frequency of liver lesions caused by anti-tuberculosis drugs, the possibility of using compounds based on oxidized glutathione for hepatoprotection is shown. Purposes and tasks. The purpose of the study was to conduct a comparative assessment of the hepatoprotective properties of molixan and glutoxim in liver lesions with anti-tuberculosis drugs. To achieve this goal, it was necessary to perform the following tasks: on the model of toxic liver damage caused by anti-tuberculosis drugs (isoniazid, rifampicin, pyrazinamide) to study the effectiveness of glutoxin and molixan by biochemical and morphological parameters; on the basis of the data to determine the most effective scheme of application. Materials and methods: the study was conducted on 90 white male not inbred rats. Antituberculosis drugs (AD) were administered to animals daily for 14 days in the following doses: isoniazid – 50 mg/kg intraperitoneal, rifampicin – 250 mg/kg and pyrazinamide – 45 mg/kg intragastrically. Glutoxim and molixan were administered daily for 14 days at doses: 20 and 40 mg/kg – glutoxim, 30 mg/kg – molixan, intraperitoneal for 2 hours before the introduction of anti-tuberculosis drugs. The animals were divided into 5 groups of 18 rats each. Group 1 – intact animals, 2 – control AD, 3 – AD + glutoxim 20 mg/kg, 4 – AD + glutoxim 40 mg/kg, 5 – AD + molixan 30 mg/kg. In the study on day 15, biochemical parameters of blood were determined, the liver was taken for morphohistological study and the level of LPO in its homogenates was determined by the concentration of diene conjugates and malondialdehyde. Results and conclusions. As a result of the experimental study, it was noted that the more pronounced hepatoprotective effect was exerted by molixan.